about
Microparticles and their role in coronary artery disease.A new method of applying randomised control study data to the individual patient: A novel quantitative patient-centred approach to interpreting composite end points.Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping.Reducing time to angiography and hospital stay for patients with high-risk non-ST-elevation acute coronary syndrome: retrospective analysis of a paramedic-activated direct access pathway.Magnetic Resonance in Transthyretin Cardiac Amyloidosis.Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar.Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG.Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention.Reply: Amyloidosis in the Era of Mass Spectrometry-Based ProteomicsCardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic RolesAcute changes in cardiac structural and tissue characterisation parameters following haemodialysis measured using cardiovascular magnetic resonanceAtrial fibrillation guidelines. Don't forget HASBLED scoreLower incidence of inappropriate shock therapy in patients with combined cardiac resynchronisation therapy defibrillators (CRT-D) compared with patients with non-CRT defibrillators (ICDs)Native T1 and Extracellular Volume in Transthyretin AmyloidosisChoice of Intracoronary Imaging: When to use Intravascular Ultrasound or Optical Coherence TomographyAcute coronary syndromesMyocardial Edema and Prognosis in AmyloidosisAutomated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary PhysiologyDo Pre-Hemodialysis Estimates of Extracellular Volume Excess Using Bioimpedance and N-Terminal Brain Natriuretic Peptide Correlate With Cardiac Chamber Size Measured by Magnetic Resonance Imaging?
P50
Q30239873-44CEF1D1-72CF-4D2A-B0D2-2DA9344AE67BQ30966990-BACFA197-31D6-4A2A-874D-CDC867CAB784Q33884781-F8C0FD16-B371-45F4-A9FA-BD54CEB06459Q37027861-CD151B85-5799-4B5D-A59E-0B9A5A041ABCQ38400944-F90E80B9-651C-4D78-A974-F3EB6B29995FQ47106346-4C49F217-D85E-45A4-8CCA-067100BD7E37Q48925804-3F56A89C-FA88-4F60-A7CA-1D95FFA519B6Q52679717-CDF1E2C6-FD69-44CD-9D89-B7B64133FA14Q57025306-17B339DC-777B-40ED-9542-7D8D30E215E1Q61657807-BCB3CF34-FFC8-45FA-9C72-7730B1277B16Q61800819-B05A1AE6-8016-4BA2-8D48-1D7BDA4FA73BQ84189459-6CEC07DB-8420-4E94-AA6F-B5DD6B893265Q87119163-2CA3BE97-ED57-4A3D-B26A-64B55E2B6CD0Q88088242-B2593296-80D0-4034-BA48-D438C04961C6Q88195747-BAE2E4B9-B376-4EA2-856B-E6FFB5F08477Q88960063-C7DE31B3-E49A-4886-919B-B40ECB27D5F2Q89180189-4A9E2766-4F71-4141-8A26-4383A71F5CC4Q91647819-58B45308-B38B-4424-9B1F-5AE54A6AC559Q93365034-093DBB2D-4738-4755-9AA5-D4FE8D9FC962
P50
description
researcher ORCID ID = 0000-0003-0059-4817
@en
wetenschapper
@nl
name
Tushar Kotecha
@ast
Tushar Kotecha
@en
Tushar Kotecha
@es
Tushar Kotecha
@nl
type
label
Tushar Kotecha
@ast
Tushar Kotecha
@en
Tushar Kotecha
@es
Tushar Kotecha
@nl
prefLabel
Tushar Kotecha
@ast
Tushar Kotecha
@en
Tushar Kotecha
@es
Tushar Kotecha
@nl
P108
P108
P31
P496
0000-0003-0059-4817